DOI:
10.1055/s-00000025
Hormone and Metabolic Research
LinksClose Window
References
Bengtsson D, Schroder HD, Andersen M. et al.
Long-term outcome and MGMT as a predictive marker in 24 patients with atypical pituitary adenomas and pituitary carcinomas given treatment with temozolomide.
J Clin Endocrinol Metab 2015;
100: 1689-1698
We do not assume any responsibility for the contents of the web pages of other providers.